Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Choosing between Sp500 and Total Market funds can shape your retirement. This guide compares performance, diversification, and allocation to help you decide.
28,514 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Fridays bring a fresh round of analyst calls that moved key names across tech and consumer staples. Investors weigh n...
AMD has surged in 2026 and is flirting with a $1 trillion market cap. This deep dive examines the drivers, risks, and...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Vuzix is aiming to turn AR glasses into practical frontline tools. This guide breaks down what vuzix (vuzi) 2026 earn...
Lenders and buyers increasingly trust AI-driven recommendations to steer them toward agents. This report shows how to...
Polestar faces a pivotal period as it refines profitability and expansion amid a crowded EV field. This report outlin...
A widening disconnect between executive teams and frontline operations is dragging down loan-technology upgrades. The...
California's new EV incentive is tilting the playing field for Rivian and Tesla. With Q1 results out, investors are w...
SoundHound AI is testing a high-growth path in voice commerce and Vision AI. This article explains why some investors...
Nvidia is a cornerstone of the AI era, and its upcoming earnings can move markets. This guide breaks down what to con...
Microsoft stock has slipped in 2026, but a strong earnings report could ignite a rebound. This guide breaks down what...